home / stock / abvc / abvc news

ABVC News and Press, ABVC BioPharma Inc. From 08/23/23

Stock Information
Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: NASDAQ
Website: abvcpharma.com
Menu
ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...
ABVC - ABVC BioPharma Provides Updates on ADHD Phase IIb Clinical Study

FREMONT, CA - ( NewMediaWire ) - August 23, 2023 -   ABVC BioPharma, Inc . (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that 60 subjects had been enrolled and 53 had co...
ABVC - Fulcrum, Renovaro top healthcare gainers; Emergent, Geron among losers

2023-08-22 10:00:48 ET Gainers: Fulcrum Therapeutics ( FULC ) +55% . Renovaro Biosciences ( RENB ) +18% . ProMIS Neurosciences ( PMN ) +17% . cbdMD ( YCBD ) +9% . 60 Degrees Pharmaceuticals ( SXTP ) +7% . Losers: Emergent BioSo...

ABVC - ABVC looks to establish a healthcare center, buys 20% stake in real estate property

2023-08-17 13:26:45 ET More on ABVC BioPharma ABVC stock rallies on Chinese licensing deal for psych drugs Thailand FDA approves ABVC BioPharma's phase 2 study plan for its eye-gel substitute ABVC Biopharma stock rises on upcoming US patent for ABV-1504 to treat depres...

ABVC - ABVC Executes Cooperation Agreement for Strategic Investments

FREMONT, CA - ( NewMediaWire ) - August 17, 2023 -   ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it had entered into a Cooperation Agr...
ABVC - ABVC BioPharma regains compliance with Nasdaq's minimum bid price requirement

2023-08-10 10:23:27 ET Clinical-stage biopharmaceutical firm ABVC BioPharma ( NASDAQ: ABVC ) Thursday said it received a letter from Nasdaq notifying that company had regained compliance with the minimum bid price requirement. The closing bid price of ABVC's common stock was a...

ABVC - ABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid Price Requirement

FREMONT, CA - ( NewMediaWire ) - August 10, 2023 - Fremont, CA - ( NewMediaWire ) - August 10, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, ...

ABVC - ABVC Corporate Update and CEO's Letter to Shareholders

FREMONT, CA - ( NewMediaWire ) - August 07, 2023 -   ABVC BioPharma, Inc.  (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, today published a  Corporate Update and...
ABVC - ABVC Announces the Approval of the Plan for GMP Production Facilities of Vitargus by Taiwan Science Park Administration

FREMONT, CA - ( NewMediaWire ) - August 3, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company specializing in therapeutic solutions in oncology/hematology, neurology, and ophthalmology, announced that the Science Park Administration in Taiwan approved th...

ABVC - ADMP, TIGR and TMC among pre-market losers

2023-08-02 08:33:20 ET Adamis Pharmaceuticals Corporation ( ADMP ) -38% . Cambium Networks Corporation CMBM -31% after Q2 earning release . Evolve Transition Infrastructure LP ( OTC:SNMP ) -29% . Latch ( LTCH ) -29% . Driven Brands Holdings ...

ABVC - ABVC stock rallies on Chinese licensing deal for psych drugs

2023-08-01 14:10:15 ET ABVC BioPharma ( NASDAQ: ABVC ) stock shot up as much as 100% Tuesday following news that it has entered into a tentative licensing deal to develop its psychiatric drug candidates ABV-1504 and ABV-1505 for the Chinese market. Shares of ABVC were up 42% at ...
Previous 10 Next 10